Marpai, Inc. announced the appointment of Dallas Scrip as its new Chief Operating Officer (COO) and President of MarpaiRx. This strategic hire is intended to accelerate profitable growth and enhance operational excellence within the company's healthcare technology and Third-Party Administration (TPA) services.
Mr. Scrip brings significant experience in scaling private equity and venture capital-owned companies, with expertise across healthcare consumer, employer, provider, and payor markets. His background includes a strong foundation in sales and business development, and he is recognized for his process-oriented approach to transforming companies through organic growth initiatives.
Damien Lamendola, CEO of Marpai, stated that the addition of Dallas Scrip to the leadership team is a pivotal step in Marpai's journey towards sustainable and profitable high growth. Scrip's deep understanding of the TPA landscape and commitment to building high-performance teams align with Marpai's vision for the future, particularly as the company focuses on its MarpaiRx program.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.